MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1371-1381

  Yang, Yang ^a   Yang, Lixia ^b   Liang, Xing ^b   Zhu, Guofu ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Atherosclerosis; Inflammation; MicroRNA 155; SOCS1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 155; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; LOW DENSITY LIPOPROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EXPERIMENTAL ATHEROSCLEROSIS; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL LINE; CELL MOTION; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; CELL LINE; CELL MOVEMENT; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICE, INBRED C57BL; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84936976894     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430303     Document Type: Article

References (43)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
2. Imanishi T, Akasaka T: Novel strategies to target inflammatory processes in atherosclerosis. Curr Pharm Design 2013;19:1616-1625.
3. Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y: Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm 2012;693083.
4. Libby P: Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 2045-2051.
5. Wang H, Eitzman DT: Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis 2013;229:18-22.
6. Mendel I, Yacov N, Harats D, Breitbart E: Therapies Targeting Innate Immunity for Fighting Inflammation in Atherosclerosis. Curr Pharm Design 2015;21:1185-1195.
7. Winter J, Jung S, Keller S, Gregory RI, Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11:228-234.
8. Contreras J, Rao DS: MicroRNAs in inflammation and immune responses. Leukemia 2012;26:404-413.
9. Rayner KJ, Fernandez-Hernando C, Moore KJ: MicroRNAs regulating lipid metabolism in atherogenesis. Thromb Haemost 2012;107:642-647.
10. Quiat D, Olson EN: MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013;123:11-18.
11. Heymans S, Corsten MF, Verhesen W, Carai P, van Leeuwen RE, Custers K, Peters T, Hazebroek M, Stöger L, Wijnands E, Janssen BJ, Creemers EE, Pinto YM, Grimm D, Schürmann N, Vigorito E, Thum T, Stassen F, Yin X, Mayr M, de Windt LJ, Lutgens E, Wouters K, de Winther MP, Zacchigna S, Giacca M, van Bilsen M, Papageorgiou AP, Schroen B: Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 2013;128:1420-1432.
12. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of MIR-155 and MIR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082-5089.
13. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM: Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infec Dis 2009;200:916-925.
14. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, Weber C, Schober A: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 2012;122:4190-4202.
15. Faraoni I, Antonetti FR, Cardone J, Bonmassar E: MIR-155 gene: A typical multifunctional microRNA. BBA-Mol Basis Dis 2009;1792:497-505.
16. O'Neill LA, Sheedy FJ, McCoy CE: MicroRNAs: The fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11:163-175.
17. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB: MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011;108:11193-11198.
18. Davey GM, Heath WR, Starr R: SOCS1: A potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue antigens 2006;67:1-9.
19. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982;42:1530-1536.
20. da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ: MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 2010;12:1220-1227.
21. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984.
22. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987;68:231-240.
23. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP: Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003;12:1413-1426.
24. Virtue A, Mai J, Yin Y, Meng S, Tran T, Jiang X, Wang H, Yang XF: Structural evidence of anti-atherogenic microRNAs. Front Biosci 2011;16:3133-3145.
25. Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-342.
26. Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, Zha L, Cao Y, Li Z, Cheng X, Zhang Y, Yang X.: Cardiomyocyte overexpression of MIR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012;22:516-527.
27. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81.
28. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY.: Secreted monocytic MIR-150 enhances targeted endothelial cell migration. Mol Cell 2010;39:133-144.
29. Tian FJ, An LN, Wang GK, Zhu JQ, Li Q, Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, Shen N, Yang HT, Zhao XX, Huang S, Qin YW, Jing Q: Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc Res 2014;103:100-110.
30. Baker BJ, Akhtar LN, Benveniste EN.: SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 2009;30:392-400.
31. He Y, Zhang W, Zhang R, Zhang H, Min W: SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem 2006;281:5559-5566.
32. Fang H, Lin J, Wang L, Xie P, Wang X, Fu J, Ai W, Chen S, Chen F, Zhang F, Su Y, Li D: Kruppel-like factor 2 regulates dendritic cell activation in patients with acute coronary syndrome. Cell Physiol Biochem 2013;32:931-941.
33. Meng Z, Yan C, Deng Q, Dong X, Duan ZM, Gao DF, Niu XL: Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4. Cell Physiol Biochem 2013;31:842-853.
34. Lin J, Chang W, Dong J, Zhang F, Mohabeer N, Kushwaha KK, Wang L, Su Y, Fang H, Li D: Thymic stromal lymphopoietin over-expressed in human atherosclerosis: potential role in Th17 differentiation. Cell Physiol Biochem 2013;31:305-318.
35. Wei Y, Nazari-Jahantigh M, Chan L, Zhu M, Heyll K, Corbalán-Campos J, Hartmann P, Thiemann A, Weber C, Schober A: The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1-and microRNA-155-dependent pathway during atherosclerosis. Circulation 2013;127:1609-1619.
36. Sullivan RP, Fogel LA, Leong JW, Schneider SE, Wong R, Romee R, Thai TH, Sexl V, Matkovich SJ, Dorn GW 2nd, French AR, Fehniger TA: MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways. J Immunol 2013;191:5904-5913.
37. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, Sheehan K, Hilton DJ, Alexander WS, Hertzog PJ: Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 2006;7:33-39.
38. Qing Y, Costa-Pereira AP, Watling D, Stark GR.: Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation. J Biol Chem 2005;280:1849-1853.
39. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T: IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003;4:491-496.
40. Ng SL, Friedman BA, Schmid S, Gertz J, Myers RM, Tenoever BR, Maniatis T: IkappaB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc Natl Acad Sci USA 2011;108:21170-21175.
41. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X: Identification of miRNomes in human liver and hepatocellular carcinoma reveals MIR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer cell 2011;19:232-243.
42. Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A, Li D, Hou Z, Lv K, Kan G, Cao H, Wu H, Song J, Pan X, Sun Q, Ling S, Li Y, Zhu M, Zhang P, Peng S, Xie X, Tang T, Hong A, Bian Z, Bai Y, Lu A, Li Y, He F, Zhang G, Li Y: MIR-214 targets ATF4 to inhibit bone formation. Nat Med 2013;19:93-100.
43. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-689.